PARVUS THERAPEUTICS

parvus-therapeutics-logo

Parvus Therapeutics is a novel class of therapeutics to reverse autoimmune disease without impairing normal immunity.

#Website #More

PARVUS THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Therapeutics Wellness

Address:
South San Francisco, California, United States

Country:
United States

Website Url:
http://www.parvustherapeutics.com

Total Employee:
11+

Status:
Active

Contact:
415-805-8251

Email Addresses:
[email protected]

Technology used in webpage:
SPF Amazon Google Maps API Amazon Route 53 Barracuda Networks


Official Site Inspections

http://www.parvustherapeutics.com

  • Host name: s3-website-us-east-1.amazonaws.com
  • IP address: 52.216.57.165
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Parvus Therapeutics"

Company - Parvus Therapeutics Inc.

About Parvus At Parvus, we are developing a pipeline of novel proprietary pMHC nanomedicine drug candidates (a.k.a. NavacimsTM) which trigger endogenous generation of regulatory T โ€ฆSee details»

Parvus Therapeutics - Crunchbase Company Profile & Funding

Organization. Parvus Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Parvus Therapeutics is a novel class of โ€ฆSee details»

Parvus Therapeutics Company Profile | Management and

Parvus Therapeutics Profile and History. Parvus Therapeutics Inc. (Parvus) is a privately held biopharmaceutical company developing Navacims, a platform technology based on โ€ฆSee details»

Parvus Therapeutics Company Profile 2024: Valuation, Funding ...

Parvus Therapeutics is headquartered in South San Francisco, CA. What is the size of Parvus Therapeutics? Parvus Therapeutics has 22 total employees. What industry is Parvus โ€ฆSee details»

Parvus Therapeutics Inc Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Parvus Therapeutics Inc of Calgary, AB. Get the latest business insights from Dun & Bradstreet.See details»

Org Chart Parvus Therapeutics - The Official Board

Organizational Chart of Parvus Therapeutics. Parvus Therapeutics www.parvustx.com. has 11 executives +1 415 805 8251; Add an executive. Parvus Therapeutics News . Anything โ€ฆSee details»

Parvus Therapeutics Company Profile - Office Locations ... - Craft

Parvus Therapeutics is a company specializing in disease-modifying therapeutics for autoimmune diseases. It develops Navacims therapeutics that target disease-causing effector T cells. โ€ฆSee details»

Parvus Therapeutics - VentureRadar

Parvus is pioneering a novel class of disease-modifying therapeutics โ€“ Navacimsโ„ข โ€“ that are designed to reverse autoimmune disease by selectively... ... Find ...See details»

Parvus Therapeutics headquarters and office locations - Craft

Parvus Therapeutics is headquartered in South San Francisco, 800 Dubuque Ave, United States, and has 1 office location.See details»

Parvus Therapeutics - Contacts, Employees, Board Members

Organization. Parvus Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Contacts 9. ... Parvus โ€ฆSee details»

Parvus Therapeutics - Products, Competitors, Financials, โ€ฆ

Parvus Therapeutics is a biopharmaceutical company focused on developing treatments for autoimmune diseases. The company's main innovation, Navacims, is a platform technology โ€ฆSee details»

Careers - Parvus Therapeutics Inc.

We are seeking extraordinary and ambitious individuals who share our drive and desire to transform medicineSee details»

Parvus Therapeutics Inc. | Insights

Mar 29, 2024 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»

Genentech signs deal with Parvus to tackle inflammatory diseases

May 17, 2019 Canadaโ€™s Parvus Therapeutics has signed a deal with Rocheโ€™s Genentech unit to develop, manufacture and market drugs for inflammatory bowel disease, autoimmune liver โ€ฆSee details»

Research Money Inc โ€“ Organizations โ€“ Parvus Therapeutics

Organization: Parvus Therapeutics Opinion Leader โ€“ The Rise of the Rest: Building a high-performance innovation ecosystem in Calgary. October 5th, 2022. Calgary demonstrates the โ€ฆSee details»

Parvus Therapeutics and Ardena Enter Agreement for Tech โ€ฆ

Nov 19, 2021 Parvus Therapeutics and Ardena Enter Agreement for Tech Transfer, Scale-Up and GMP Manufacturing of Navacim Nanoparticles. SOUTH SAN FRANCISCO, CALIFORNIA โ€ฆSee details»

How Parvus Therapeutics Inc. Discovered a New Class of Drugs

Jun 9, 2021 The path of development to clinical trials and commercialization to those drugs had already been blazed, while Santamaria and Parvus Therapeutics had to blaze their own trail. โ€ฆSee details»

Genentech, Parvus In $800-Million-Plus Licensing Deal For โ€ฆ

May 23, 2019 Rocheโ€™s Genentech has entered into a global collaboration and licensing agreement with Parvus Therapeutics, a privately held biopharmaceutical company, to develop, โ€ฆSee details»

News - Parvus Therapeutics Inc.

Parvus Therapeutics, a private clinical-stage biopharmaceutical company developing a pipeline of novel treatments for autoimmune disease announced the successful dosing of the first subject โ€ฆSee details»